Medtronic plc (Dublin, Ireland) and Medicrea have entered into a tender offer agreement for the acquisition of all outstanding shares of Medicrea. The voluntary all-cash tender offer will be at a price of about $8 per Medicrea share.
Medicrea’s product portfolio includes MEDICREA UNiD ASI (Adaptive Spine Intelligence) designed to support surgeon workflow in pre-operative planning and create personalized implant solutions for surgery. The Medicrea solution is powered by predictive modeling and sophisticated algorithms that measure and digitally reconstruct the spine to its optimal profile.
Medtronic says the acquisition will “strengthen Medtronic’s position as a global innovator in enabling technologies and solutions for spine surgery.”
Assuming receipt of regulatory and other clearances and satisfaction of other closing conditions, the acquisition is expected to close by the end of calendar year 2020.